COLTENE competes in the specialized dental supplies market with a focus on mechanical instruments and filling materials. The company maintains profitability with EBIT margins around 11% and targets growth exceeding market rates (3-5% vs. market 1-3%), supported by production facilities across Switzerland, the US, Germany, and Hungary.
Cyborg Score Rationale
COLTENE demonstrates solid fundamentals with $277M TTM revenue, $422M market cap, and profitable operations. The company achieves above-market growth targets and maintains reasonable margins, though it operates in a modest-scale, competitive medical supplies segment with limited growth catalysts.
Top Insights
Global diversification across six geographic regions reduces regional dependency and captures international dental market growth
Product portfolio spans full dental workflow from treatment to lab work, providing customer stickiness through bundled offerings
Targeting 3-5% growth outpacing market at 1-3%, with margin expansion plans to 13-15% EBIT medium-term